Shane C. Quinonez

Shane C. Quinonez

Auto-generated profile, based on publicly available information

Shane C. Quinonez

Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Molecular Genetics and Metabolism
Verified
Journal Article
Open access
SQShane C. Quinonez
Shane C. Quinonez
JIJeffrey W. Innis
Jeffrey W. Innis
The Hox genes are an evolutionarily conserved family of genes, which encode a class of important transcription factors that function in numerous developmental processes. Following their initial discovery, a substantial amount of information has been gained regarding the roles Hox genes play in various physiologic and pathologic processes. These processes range from a central role in anterior-posterior patterning of the developing embryo to roles in oncogenesis that are yet to be fully elucidated. In vertebrates there are a total of 39 Hox genes divided into 4 separate clusters. Of these, mutations in 10 Hox genes have been found to cause human disorders with significant variation in their inheritance patterns, penetrance, expressivity and mechanism of pathogenesis. This review aims to describe the various phenotypes caused by germline mutation in these 10 Hox genes that cause a human phenotype, with specific emphasis paid to the genotypic and phenotypic differences between allelic disorders. As clinical whole exome and genome sequencing is increasingly utilized in the future, we predict that additional Hox gene mutations will likely be identified to cause distinct human phenotypes. As the known human phenotypes closely resemble gene-specific murine models, we also review the homozygous loss-of-function mouse phenotypes for the 29 Hox genes without a known human disease. This review will aid clinicians in identifying and caring for patients affected with a known Hox gene disorder and help recognize the potential for novel mutations in patients with phenotypes informed by mouse knockout studies.

3 July 2013 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
SQShane C. Quinonez
Shane C. Quinonez
JPJohn M. Park
John M. Park
RRRaja Rabah
Raja Rabah
KOKailey M. Owens
Kailey M. Owens
BYBeverly M. Yashar
Beverly M. Yashar
CKCatherine E. Keegan
Catherine E. Keegan

1 January 2013 in Pediatric Neurology
Verified
Journal Article
Closed access
SQShane C. Quinonez
Shane C. Quinonez
SLSteven M. Leber
Steven M. Leber
DMDonna Martin
Donna Martin
JTJess G. Thoene
Jess G. Thoene
Jirair K. BedoyanJirair K. Bedoyan
Jirair K. Bedoyan

17 August 2012 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
SQShane C. Quinonez
Shane C. Quinonez
Peter HederaPeter Hedera
Peter Hedera
MBMason Barr
Mason Barr
TATodd Ackley
Todd Ackley
CLCindy Lam
Cindy Lam
JIJeffrey W. Innis
Jeffrey W. Innis

14 October 2016 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
SQShane C. Quinonez
Shane C. Quinonez
TGThomas D. Gelehrter
Thomas D. Gelehrter
WUWendy R. Uhlmann
Wendy R. Uhlmann

23 July 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SQShane C. Quinonez
Shane C. Quinonez
BOBridget C. O’cOnnor
Bridget C. O’cOnnor
MJMichelle F. Jacobs
Michelle F. Jacobs
ATAtnafu Mekonnen Tekleab
Atnafu Mekonnen Tekleab
AMAyalew Marye
Ayalew Marye
GWGetahun Wedaje
Getahun Wedaje
Background: Over the past two decades non-communicable diseases (NCDs) have steadily increased as a cause of worldwide disability and mortality with a concomitant decrease in disease burden from communicable, maternal, neonatal and nutritional conditions. Congenital anomalies, the most common NCD affecting children, have recently become the fifth leading cause of under-five mortality worldwide, ahead of other conditions such as malaria, neonatal sepsis and malnutrition. Genetic counseling has been shown to be an effective method to decrease the impact of congenital anomalies and genetic conditions but is absent in almost all sub-Saharan Africa countries. To address this need for counseling services we designed and implemented the first broad-based genetic counseling curriculum in Ethiopia, launching it at St. Paul’s Millennium Medical College (SPHMMC) in Addis Ababa, Ethiopia.Methods: The curriculum, created by Michigan Medicine and SPHMMC specialists, consisted of medical knowledge and genetic counseling content and was delivered to two cohorts of nurses. Curriculum evaluation consisted of satisfaction surveys and pre- and post-assessments covering medical knowledge and genetic counseling content. Following Cohort 1 training, the curriculum was modified to increase the medical knowledge material and decrease Western genetic counseling principles material.Results: Both cohorts reported high levels of satisfaction but felt the workshop was too short. No significant improvements in assessment scores were seen for Cohort 1 in terms of total scores and medical knowledge and genetic counseling-specific questions. Following curriculum modification, improvements were seen in Cohort 2 with an increase in total assessment scores from 63% to 73% (p = 0.043), with medical knowledge-specific questions increasing from 57% to 79% (p = 0.01) with no significant change in genetic counseling-specific scores. Multiple logistic, financial, cultural and systems-specific barriers were identified with recommendations for their consideration presented.Conclusion: Genetics medical knowledge of Ethiopian nurses increased significantly following curriculum delivery though difficulty was encountered with Western genetic counseling material.